RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

$116.30
-0.05 (-0.04%)
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 23 82%
Hold 5 18%
Sell 0 0%
Price Target
Analyst Price Target -46.6% upside
Low Target $40.44
Average Target $62.10
High Target $74.58
Current Price $116.30
Current
$116.30
Target
$62.10
$40.44 $62.10 avg $74.58
Scenario Analysis
Bear Case
$40.44
-65.2%
Low target
Base Case
$62.10
-46.6%
Avg target
Bull Case
$74.58
+-35.9%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$175.77
-33.8% from high
52-Week Low
$102.97
+13.0% from low
50-Day SMA
$157.63
-26.2% vs SMA
200-Day SMA
$139.06
-16.4% vs SMA
RSI (14)
28.0
Oversold
Target vs 52W High
$62.10
-64.7% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 88% $369.21 -24.9%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -16.8%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -43.4%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -50.1%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -86.5%
ILMN
Illumina Inc
Hold 28 54% $169.36 +34.4%
WAT
Waters Corp
Buy 28 57% $189.60 -37.2%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -44.8%